Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes

The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AMMENN JOCHEN, SLIEKER LAWRENCE JOHN, SNYDER NANCY JUNE, ROBERTSON MICHAEL ALAN, KINNICK MICHAEL DEAN, MORIN, JR. JOHN MICHAEL, GILLIG JAMES RONALD, SAVIN KENNETH ALLEN, SCHOTTEN THEO, HEINZ LAWRENCE JOSEPH, LAI YEN-SHI, OTT CARSTEN, HIPSKIND PHILIP ARTHUR, NIXON JAMES ARTHUR
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.